uniQure (QURE) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

uniQure Revenue Highlights

Latest Revenue (Y)

$27.12M

Latest Revenue (Q)

$3.70M

Main Segment (Y)

Collaboration revenues

uniQure Revenue by Period

uniQure Revenue by Year

Date	Revenue	Change
2024-12-31	$27.12M	71.17%
2023-12-31	$15.84M	-85.12%
2022-12-31	$106.48M	-79.68%
2021-12-31	$524.00M	1296.82%
2020-12-31	$37.51M	415.23%
2019-12-31	$7.28M	-35.48%
2018-12-31	$11.28M	-13.91%
2017-12-31	$13.11M	-47.78%
2016-12-31	$25.10M	143.57%
2015-12-31	$10.30M	80.87%
2014-12-31	$5.70M	40.19%
2013-12-31	$4.06M	100.00%
2012-12-31	-	100.00%
2011-12-31	-	-

uniQure generated $27.12M in revenue during NA 2024, up 71.17% compared to the previous quarter, and up 372.46% compared to the same period a year ago.

uniQure Revenue by Quarter

Date	Revenue	Change
2025-09-30	$3.70M	-29.67%
2025-06-30	$5.26M	235.80%
2025-03-31	$1.57M	-69.99%
2024-12-31	$5.22M	128.29%
2024-09-30	$2.29M	-79.44%
2024-06-30	$11.13M	31.13%
2024-03-31	$8.48M	26.85%
2023-12-31	$6.69M	375.41%
2023-09-30	$1.41M	-41.91%
2023-06-30	$2.42M	-54.52%
2023-03-31	$5.33M	-94.82%
2022-12-31	$102.75M	6990.75%
2022-09-30	$1.45M	191.55%
2022-06-30	$497.00K	-72.27%
2022-03-31	$1.79M	-96.89%
2021-12-31	$57.69M	2800.50%
2021-09-30	$1.99M	-99.57%
2021-06-30	$463.87M	102073.57%
2021-03-31	$454.00K	-98.67%
2020-12-31	$34.09M	1805.31%
2020-09-30	$1.79M	16.55%
2020-06-30	$1.53M	1375.96%
2020-03-31	$104.00K	-96.04%
2019-12-31	$2.63M	150.96%
2019-09-30	$1.05M	-57.72%
2019-06-30	$2.47M	117.78%
2019-03-31	$1.14M	-29.35%
2018-12-31	$1.61M	-48.92%
2018-09-30	$3.15M	3.21%
2018-06-30	$3.05M	-12.31%
2018-03-31	$3.48M	34.60%
2017-12-31	$2.58M	14.34%
2017-09-30	$2.26M	-54.27%
2017-06-30	$4.94M	48.81%
2017-03-31	$3.32M	-63.28%
2016-12-31	$9.05M	24.69%
2016-09-30	$7.25M	65.48%
2016-06-30	$4.38M	-0.87%
2016-03-31	$4.42M	19.61%
2015-12-31	$3.70M	4.31%
2015-09-30	$3.54M	95.67%
2015-06-30	$1.81M	51.10%
2015-03-31	$1.20M	-26.00%
2014-12-31	$1.62M	27.54%
2014-09-30	$1.27M	-10.65%
2014-06-30	$1.42M	-11.65%
2014-03-31	$1.61M	24.13%
2013-12-31	$1.30M	-25.70%
2013-09-30	$1.74M	76.93%
2013-06-30	$986.16K	100.00%
2013-03-31	-	100.00%
2012-12-31	-	-

uniQure generated $3.70M in revenue during Q3 2025, up -29.67% compared to the previous quarter, and up 33.26% compared to the same period a year ago.

uniQure Revenue Breakdown

uniQure Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
License revenues	$10.13M	$2.76M	$100.00M	$517.40M	-
Collaboration revenues	$10.87M	$2.25M	$4.77M	$6.60M	-
License revenues from related party	-	-	-	-	-
License Revenue From Related Party	-	-	-	-	$32.97M
License	-	-	-	-	$4.35M
Collaborative Revenue	-	-	-	-	$59.00K
Collaborative Revenue From Related Party	-	-	-	-	$136.00K

uniQure's latest annual revenue breakdown by segment (product or service), as of Dec 24: Collaboration revenues (51.76%), and License revenues (48.24%).

Quarterly Revenue by Product

Product/Service	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Collaboration revenues	$119.00K	$246.00K	$200.00K	$7.13M	$3.29M	$1.54M	$319.00K	$388.00K	$1.03M	$1.45M	$497.00K	$1.79M	$2.69M	-	-	-	-	-	-	-
License revenues	$3.58M	$5.26M	$1.57M	$4.95M	$2.11M	$1.87M	$1.20M	$1.97M	$793.00K	$55.00M	-	-	-	-	-	-	-	-	-	-
License	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$462.40M	-	-	-
Collaborative Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.99M	$1.47M	$454.00K	-	-
Collaborative Revenue From Related Party	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$61.00K	$13.00K
License Revenue From Related Party	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.61M	$1.78M

uniQure's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: License revenues (96.78%), and Collaboration revenues (3.22%).

uniQure Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
GLPG	Galapagos	$239.70M	$62.43M
OCUL	Ocular Therapeutix	$63.46M	$14.54M
ABCL	AbCellera Biologics	$28.83M	$8.96M
QURE	uniQure	$27.12M	$3.70M
NUVB	Nuvation Bio	$7.87M	$13.12M
MESO	Mesoblast	$7.50M	$1.69M
CLDX	Celldex Therapeutics	$7.02M	-
GPCR	Structure Therapeutics	-	-
VRDN	Viridian Therapeutics	-	$70.57M
EWTX	Edgewise Therapeutics	-	-
VERA	Vera Therapeutics	-	-

QURE Revenue FAQ

What is uniQure’s yearly revenue?

uniQure's yearly revenue for 2024 was $27.12M, representing an increase of 71.17% compared to 2023. The company's yearly revenue for 2023 was $15.84M, representing a decrease of -85.12% compared to 2022. QURE's yearly revenue for 2022 was $106.48M, representing a decrease of -79.68% compared to 2021.

What is uniQure’s quarterly revenue?

uniQure's quarterly revenue for Q3 2025 was $3.7M, a -29.67% decrease from the previous quarter (Q2 2025), and a 61.83% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $5.26M, a 235.80% increase from the previous quarter (Q1 2025), and a -52.71% decrease year-over-year (Q2 2024). QURE's quarterly revenue for Q1 2025 was $1.57M, a -69.99% decrease from the previous quarter (Q4 2024), and a -81.53% decrease year-over-year (Q1 2024).

What is uniQure’s revenue growth rate?

uniQure's revenue growth rate for the last 3 years (2022-2024) was -74.53%, and for the last 5 years (2020-2024) was -27.71%.

What are uniQure’s revenue streams?

uniQure's revenue streams in c 24 are License revenues, and Collaboration revenues. License revenues generated $10.13M in revenue, accounting 48.24% of the company's total revenue, up 267.40% year-over-year. Collaboration revenues generated $10.87M in revenue, accounting 51.76% of the company's total revenue, up 383.20% year-over-year.

What is uniQure’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of uniQure was Collaboration revenues. This segment made a revenue of $10.87M, representing 51.76% of the company's total revenue.